X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12472) 12472
Book Chapter (68) 68
Dissertation (13) 13
Newsletter (10) 10
Magazine Article (9) 9
Publication (7) 7
Conference Proceeding (5) 5
Newspaper Article (5) 5
Book / eBook (4) 4
Government Document (3) 3
Reference (2) 2
Journal / eJournal (1) 1
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8474) 8474
tumor-infiltrating lymphocytes (6341) 6341
oncology (5584) 5584
female (4760) 4760
lymphocytes, tumor-infiltrating - immunology (4494) 4494
immunotherapy (3862) 3862
cancer (3590) 3590
male (3071) 3071
animals (3011) 3011
middle aged (3011) 3011
immunology (2996) 2996
lymphocytes (2563) 2563
aged (2557) 2557
prognosis (2454) 2454
adult (2192) 2192
expression (2092) 2092
mice (1988) 1988
tumors (1972) 1972
melanoma (1728) 1728
lymphocytes, tumor-infiltrating - pathology (1637) 1637
survival (1602) 1602
immunohistochemistry (1595) 1595
t cells (1500) 1500
lymphocytes, tumor-infiltrating - metabolism (1441) 1441
t-cells (1298) 1298
chemotherapy (1188) 1188
t-lymphocytes - immunology (1188) 1188
cd8-positive t-lymphocytes - immunology (1182) 1182
dendritic cells (1170) 1170
breast cancer (1143) 1143
carcinoma (1122) 1122
medicine, research & experimental (1120) 1120
aged, 80 and over (1068) 1068
melanoma - immunology (1052) 1052
metastasis (1006) 1006
neoplasms - immunology (1000) 1000
lymphocytes t (987) 987
care and treatment (984) 984
pathology (974) 974
metastatic melanoma (955) 955
research (951) 951
analysis (922) 922
regulatory t-cells (899) 899
t-lymphocytes, cytotoxic - immunology (886) 886
neoplasm staging (883) 883
antigens (881) 881
apoptosis (855) 855
tumor cells, cultured (850) 850
cell line, tumor (849) 849
gene expression (831) 831
cells (822) 822
flow cytometry (804) 804
cell biology (789) 789
antigens, neoplasm - immunology (751) 751
neoplasms - therapy (747) 747
mice, inbred c57bl (745) 745
metastases (742) 742
therapy (731) 731
tumor microenvironment (723) 723
interleukin-2 (720) 720
medical prognosis (715) 715
surgery (694) 694
immune system (668) 668
immunotherapy - methods (658) 658
cd8 antigen (657) 657
patients (652) 652
treatment outcome (634) 634
health aspects (610) 610
t-lymphocytes, regulatory - immunology (608) 608
immunotherapy, adoptive (601) 601
melanoma - therapy (600) 600
immunity (598) 598
immune response (596) 596
cytotoxicity, immunologic (595) 595
in-vivo (595) 595
adoptive immunotherapy (588) 588
melanoma - pathology (588) 588
cytotoxicity (586) 586
lymphocytes, tumor-infiltrating - drug effects (578) 578
tumor infiltrating lymphocytes (578) 578
biomarkers (577) 577
antigen (567) 567
pd-l1 (563) 563
cytokines (559) 559
activation (558) 558
t-lymphocyte subsets - immunology (558) 558
colorectal cancer (556) 556
medicine & public health (553) 553
lymphocyte activation (552) 552
inflammation (539) 539
tumor microenvironment - immunology (527) 527
chemical and pharmacologic phenomena (526) 526
breast neoplasms - immunology (524) 524
phenotype (523) 523
cancer therapies (520) 520
peripheral-blood (520) 520
cd4-positive t-lymphocytes - immunology (519) 519
breast neoplasms - pathology (513) 513
retrospective studies (490) 490
identification (488) 488
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12317) 12317
French (107) 107
Chinese (104) 104
Japanese (98) 98
German (53) 53
Spanish (19) 19
Russian (15) 15
Czech (12) 12
Italian (10) 10
Polish (10) 10
Portuguese (7) 7
Hungarian (6) 6
Korean (6) 6
Norwegian (4) 4
Serbian (3) 3
Arabic (1) 1
Finnish (1) 1
Georgian (1) 1
Romanian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer research (Chicago, Ill.), ISSN 0008-5472, 02/2011, Volume 71, Issue 4, pp. 1263 - 1271
The tumor microenvironment includes a complex network of immune T-cell subpopulations. In this study, we systematically analyzed the balance between cytotoxic... 
BREAST-CANCER | SURVIVAL | LUNG-CANCER | FOXP3 EXPRESSION | RECRUITMENT | ONCOLOGY | GASTRIC-CANCER | EOSINOPHILS | MACROPHAGES | CARCINOMA | LYMPHOCYTES | Th1 Cells - pathology | Th1 Cells - physiology | Prognosis | Th2 Cells - physiology | Tissue Array Analysis | Colorectal Neoplasms - genetics | Humans | Gene Expression Regulation, Neoplastic | Carcinoma - mortality | Gene Expression Profiling | Th2 Cells - immunology | Th1 Cells - immunology | Colorectal Neoplasms - diagnosis | Lymphocytes, Tumor-Infiltrating - physiology | T-Lymphocytes, Cytotoxic - pathology | Th1 Cells - metabolism | Th17 Cells - metabolism | Forkhead Transcription Factors - metabolism | Microarray Analysis | T-Lymphocytes, Helper-Inducer - immunology | Lymphocytes, Tumor-Infiltrating - metabolism | T-Lymphocytes, Helper-Inducer - pathology | Interleukin-4 - genetics | Th2 Cells - pathology | Th17 Cells - pathology | Colorectal Neoplasms - mortality | T-Lymphocytes, Cytotoxic - immunology | Th17 Cells - physiology | T-Lymphocytes, Helper-Inducer - metabolism | Carcinoma - immunology | Interleukin-4 - metabolism | Carcinoma - diagnosis | Forkhead Transcription Factors - genetics | Th2 Cells - metabolism | T-Lymphocytes, Cytotoxic - physiology | T-Lymphocytes, Helper-Inducer - physiology | Colorectal Neoplasms - immunology | Lymphocytes, Tumor-Infiltrating - pathology | T-Lymphocytes, Cytotoxic - metabolism | Survival Analysis | Th17 Cells - immunology | Carcinoma - genetics | Cohort Studies | Lymphocytes, Tumor-Infiltrating - immunology
Journal Article
British journal of cancer, ISSN 1532-1827, 2015, Volume 112, Issue 9, pp. 1501 - 1509
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 06/2011, Volume 108, Issue 26, pp. 10656 - 10661
Journal Article
The Journal of experimental medicine, ISSN 1540-9538, 2013, Volume 210, Issue 9, pp. 1695 - 1710
Treatment with monoclonal antibody specific for cytotoxic T lymphocyte–associated antigen 4 (CTLA-4... 
EFFECTOR | MEDICINE, RESEARCH & EXPERIMENTAL | CTLA-4 BLOCKADE | LYMPHOCYTE-ASSOCIATED ANTIGEN-4 | CANCER-PATIENTS | IN-VIVO | COMBINATION IMMUNOTHERAPY | MONOCLONAL-ANTIBODY | IMMUNOLOGY | LARGE ESTABLISHED MELANOMA | GAMMA-RIV | ANTITUMOR-ACTIVITY | Fas Ligand Protein - metabolism | Lymph Nodes - pathology | Antibodies, Blocking - pharmacology | Lymphocyte Depletion | Granulocyte-Macrophage Colony-Stimulating Factor - therapeutic use | Receptors, IgG - metabolism | T-Lymphocytes, Regulatory - immunology | Signal Transduction - immunology | Melanoma - prevention & control | Lymph Nodes - drug effects | Cell Membrane - metabolism | Clone Cells | Cell Membrane - drug effects | Tumor Microenvironment - drug effects | Phagocytes - drug effects | Mice, Inbred C57BL | Treatment Outcome | Lymph Nodes - immunology | Lymphocytes, Tumor-Infiltrating - drug effects | Melanoma - pathology | Phagocytes - immunology | TNF-Related Apoptosis-Inducing Ligand - metabolism | Tumor Microenvironment - immunology | T-Lymphocytes, Regulatory - drug effects | Animals | Lymphocytes, Tumor-Infiltrating - pathology | Signal Transduction - drug effects | Melanoma - immunology | CD8-Positive T-Lymphocytes - drug effects | Antibodies, Blocking - therapeutic use | Lymphocyte Count | Mice | CD11b Antigen - metabolism | CD8-Positive T-Lymphocytes - immunology | CTLA-4 Antigen - antagonists & inhibitors | Melanoma - therapy | CD4 Antigens - metabolism | Lymphocytes, Tumor-Infiltrating - immunology
Journal Article
Nature (London), ISSN 1476-4687, 2018, Volume 558, Issue 7710, pp. 454 - 459
The expression of co-inhibitory receptors, such as CTLA-4 and PD-1, on effector T cells is a key mechanism for ensuring immune homeostasis. Dysregulated... 
PATHWAYS | NETWORK | ACTIVATION | MAF | INTERLEUKIN-27 | LANDSCAPE | MULTIDISCIPLINARY SCIENCES | CENTRAL-NERVOUS-SYSTEM | TIM-3 | EXPRESSION | EXHAUSTION | CD8-Positive T-Lymphocytes - cytology | Male | CD4-Positive T-Lymphocytes - immunology | Immune Tolerance - immunology | Melanoma - genetics | CD8-Positive T-Lymphocytes - metabolism | Female | Lymphocytes, Tumor-Infiltrating - metabolism | Transcription, Genetic | Lymphocytes, Tumor-Infiltrating - cytology | Reproducibility of Results | Gene Regulatory Networks - genetics | Interleukin-27 - immunology | CD4-Positive T-Lymphocytes - cytology | Mice, Inbred C57BL | CD4-Positive T-Lymphocytes - metabolism | Receptors, Cell Surface - metabolism | Positive Regulatory Domain I-Binding Factor 1 - metabolism | Mice, Knockout | Animals | Melanoma - immunology | Immune Tolerance - genetics | Proto-Oncogene Proteins c-maf - metabolism | Mice | CD8-Positive T-Lymphocytes - immunology | Lymphocytes, Tumor-Infiltrating - immunology | Receptors, Cell Surface - genetics | Genetic aspects | Genetic transcription | Observations | T cells | Transcription factors | PD-1 protein | CD8 antigen | Gene regulation | Homeostasis | Effector cells | Lymphocytes T | Genomes | CD223 antigen | Immunity | Interleukin 27 | Proteins | Receptors | CTLA-4 protein | Lymphocytes | Bioinformatics | Cytokines | Immunoregulation | Melanoma | Protein C | c-Maf protein | Activated protein C | Gene expression | Ribonucleic acid--RNA | Molecular chains | CD4 antigen | Exhaustion | Computer applications | Receptor mechanisms | Bayesian analysis | Tumors
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 2011, Volume 109, Issue 8, pp. 2796 - 2801
Retrospective clinical studies have used immune-based biomarkers, alone or in combination, to predict survival outcomes for women with breast cancer (BC);... 
T lymphocytes | Cytometry | Lymphocytes | Breasts | BREAST CANCER SPECIAL FEATURE | Residual neoplasm | Breast cancer | Leukocytes | Macrophages | Tumors | Cancer | Inflammation | Macrophage | INFILTRATING LYMPHOCYTES | MULTIDISCIPLINARY SCIENCES | VEGF EXPRESSION | macrophage | MICROVESSEL DENSITY | MAMMARY-TUMORS | inflammation | MOUSE MODEL | REGULATORY T-CELLS | TUMOR-ASSOCIATED MACROPHAGES | CARCINOMA | PROGRESSION | ENDOTHELIAL GROWTH-FACTOR | Neoplasm, Residual - pathology | Leukocytes - pathology | Breast Neoplasms - immunology | Humans | Antineoplastic Agents - therapeutic use | Cell Lineage - drug effects | Antigens, CD - metabolism | Leukocytes - immunology | Lymphocyte Activation - immunology | Myeloid Cells - immunology | T-Lymphocytes - drug effects | Biomarkers, Tumor - metabolism | Female | Myeloid Cells - drug effects | Neoadjuvant Therapy | Neoplasm, Residual - immunology | Antineoplastic Agents - pharmacology | T-Lymphocytes - pathology | Cytotoxicity, Immunologic - drug effects | Lymphocytes, Tumor-Infiltrating - drug effects | Breast Neoplasms - drug therapy | Cell Movement - drug effects | Phenotype | Lymphocytes, Tumor-Infiltrating - pathology | Breast Neoplasms - pathology | Lymphocyte Activation - drug effects | Antigens, Differentiation, Myelomonocytic - metabolism | Leukocytes - drug effects | T-Lymphocytes - immunology | Myeloid Cells - pathology | Lymphocytes, Tumor-Infiltrating - immunology | Physiological aspects | Development and progression | Health aspects | Biological Sciences
Journal Article
The Journal of clinical investigation, ISSN 0021-9738, 2011, Volume 121, Issue 6, pp. 2350 - 2360
Journal Article
Nature (London), ISSN 0028-0836, 2019, Volume 571, Issue 7764, pp. 270 - 270
Tumour-specific CD8 T cell dysfunction is a differentiation state that is distinct from the functional effector or memory T cell states(1-6). Here we identify... 
EFFECTOR | AUTOIMMUNITY | MULTIDISCIPLINARY SCIENCES | GENERATION | DYSFUNCTION | PROTEINS | PROMOTES | EXPRESSION | EXHAUSTION | PROGRAM | ANTIGEN | CD8-Positive T-Lymphocytes - cytology | CD8-Positive T-Lymphocytes - pathology | Epigenesis, Genetic | Homeodomain Proteins - metabolism | Humans | Gene Expression Regulation, Neoplastic | CD8-Positive T-Lymphocytes - metabolism | Lymphocytes, Tumor-Infiltrating - metabolism | Receptors, Antigen, T-Cell - immunology | Transcription, Genetic | Lymphocytes, Tumor-Infiltrating - cytology | High Mobility Group Proteins - metabolism | High Mobility Group Proteins - deficiency | Homeodomain Proteins - genetics | Cell Differentiation - immunology | Phenotype | Animals | Lymphocytes, Tumor-Infiltrating - pathology | Neoplasms - immunology | Immunologic Memory | Mice | CD8-Positive T-Lymphocytes - immunology | Neoplasms - pathology | High Mobility Group Proteins - genetics | Lymphocytes, Tumor-Infiltrating - immunology | Physiological aspects | Genetic aspects | T cells | Cell differentiation | Tumors | Chromatin | Transcription factors | CD8 antigen | Differentiation (biology) | Chronic infection | Effector cells | Stimulation | Infections | Activation | Lymphocytes T | Genomes | NF-AT protein | Ovarian cancer | T-cell receptor | Liver cancer | Receptors | Cell activation | Clonal deletion | Listeria | Lymphocytes | Bioinformatics | Hepatocyte nuclear factor 1 | Deoxyribonucleic acid--DNA | Antigens | Data analysis | Immunological memory | Memory cells | Cloning | Melanoma | T cell receptors | Cell death | Exhaustion | Stem cells | Receptor mechanisms | Viral infections
Journal Article
Human pathology, ISSN 0046-8177, 2013, Volume 44, Issue 10, pp. 2055 - 2063
Summary Tumor-infiltrating lymphocytes (TILs) convey clinically relevant information for primary breast cancers (PBCs... 
Pathology | Breast cancer | Regulatory T cells (Treg) | Tumor-infiltrating lymphocytes (TILs) | FoxP3 | SUBTYPES | REGULATORY T-CELLS | PATHOLOGY | CARCINOMA | EXPRESSION | CHEMOTHERAPY | T-Lymphocytes, Regulatory - metabolism | Receptors, Estrogen - metabolism | CD8-Positive T-Lymphocytes - pathology | Breast Neoplasms - immunology | Tissue Array Analysis | Humans | Middle Aged | Brain Neoplasms - pathology | Carcinoma, Ductal, Breast - immunology | Receptor, ErbB-2 - metabolism | Tumor Microenvironment | Carcinoma, Ductal, Breast - mortality | Brain Neoplasms - metabolism | T-Lymphocytes, Regulatory - pathology | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Lymphocyte Subsets - metabolism | Forkhead Transcription Factors - metabolism | Biomarkers, Tumor - metabolism | CD8-Positive T-Lymphocytes - metabolism | Mastectomy | Adult | Female | Lymphocytes, Tumor-Infiltrating - metabolism | B-Lymphocytes - pathology | Carcinoma, Ductal, Breast - metabolism | Lymphocyte Subsets - pathology | B-Lymphocytes - metabolism | Carcinoma, Ductal, Breast - secondary | Maryland - epidemiology | Immunophenotyping | Survival Rate | Pilot Projects | Lymphocytes, Tumor-Infiltrating - pathology | Breast Neoplasms - pathology | Breast Neoplasms - mortality | Relapse | Analysis | Estrogen | Progesterone | Metastasis | T cells | Diseases | Studies | Chemotherapy | Lymphocytes | Tumors | breast cancer | tumor infiltrating lymphocytes (TILs) | regulatory T cells (Treg)
Journal Article